{
    "hands_on_practices": [
        {
            "introduction": "A key to understanding pathogen survival is grasping how they generate energy in different environments. *Trypanosoma brucei* is a master of metabolic adaptation, switching its energy production strategy as it moves from the tsetse fly to the mammalian bloodstream. This practice () allows you to quantify the dramatic difference in ATP production between these two life stages, making the abstract concept of metabolic switching tangible through a direct calculation of cellular energy flux.",
            "id": "4683913",
            "problem": "Trypanosoma brucei (T. brucei), the causative agent of African trypanosomiasis (African sleeping sickness), exhibits stage-specific energy metabolism. In the mammalian bloodstream form, it relies predominantly on glycolysis in specialized organelles called glycosomes, whereas in the insect (tsetse fly) midgut procyclic form, it can support Adenosine Triphosphate (ATP) generation through oxidative phosphorylation in the mitochondrion. Consider a single cell in each stage operating at steady state, where the number of ATP molecules produced per glucose molecule is constant and each glucose molecule taken up is metabolized to completion in that pathway. \n\nAssume the following experimentally motivated parameters for this thought experiment:\n- Bloodstream form glycolytic net yield: $2$ ATP per glucose, with a glucose uptake rate of $10$ molecules per second.\n- Procyclic form oxidative phosphorylation net yield: $30$ ATP per glucose, with a glucose uptake rate of $3$ molecules per second.\n\nUnder these assumptions and starting from first principles of metabolic stoichiometry and flux, determine the difference in instantaneous ATP production rates between the procyclic and bloodstream forms, defined as $\\Delta r_{\\mathrm{ATP}} = r_{\\mathrm{ATP,\\,procyclic}} - r_{\\mathrm{ATP,\\,bloodstream}}$. Express your final answer in molecules per second. No rounding is required.",
            "solution": "The problem has been validated and is determined to be scientifically sound, well-posed, and self-contained. The solution will proceed by calculating the ATP production rate for each life cycle stage of *Trypanosoma brucei* and then finding the difference.\n\nThe fundamental principle governing the production rate of a metabolite is that it is the product of the substrate consumption rate and the stoichiometric yield of the product from the substrate. This can be expressed as a general formula:\n$$r_{\\mathrm{product}} = r_{\\mathrm{substrate}} \\times Y_{\\mathrm{product/substrate}}$$\nwhere $r$ represents a rate (in molecules per unit time) and $Y$ represents the yield (in molecules of product per molecule of substrate).\n\nFor this specific problem, we are interested in the rate of ATP production, $r_{\\mathrm{ATP}}$, from the consumption of glucose. The variables are:\n- $r_{\\mathrm{ATP}}$: The instantaneous rate of ATP production in molecules per second.\n- $r_{\\mathrm{glucose}}$: The rate of glucose uptake in molecules per second.\n- $Y_{\\mathrm{ATP/glucose}}$: The net yield of ATP molecules per molecule of glucose.\n\nThe governing equation is:\n$$r_{\\mathrm{ATP}} = Y_{\\mathrm{ATP/glucose}} \\times r_{\\mathrm{glucose}}$$\n\nFirst, we calculate the ATP production rate for the bloodstream form, denoted as $r_{\\mathrm{ATP,\\,bloodstream}}$. The problem provides the following parameters for this stage:\n- The net yield from glycolysis is $Y_{\\mathrm{ATP/glucose,\\,bloodstream}} = 2$ ATP molecules per glucose molecule.\n- The glucose uptake rate is $r_{\\mathrm{glucose,\\,bloodstream}} = 10$ glucose molecules per second.\n\nSubstituting these values into the governing equation:\n$$r_{\\mathrm{ATP,\\,bloodstream}} = Y_{\\mathrm{ATP/glucose,\\,bloodstream}} \\times r_{\\mathrm{glucose,\\,bloodstream}}$$\n$$r_{\\mathrm{ATP,\\,bloodstream}} = 2 \\times 10 = 20$$\nThe rate of ATP production in the bloodstream form is $20$ molecules per second.\n\nNext, we calculate the ATP production rate for the procyclic form, denoted as $r_{\\mathrm{ATP,\\,procyclic}}$. The parameters given for this stage are:\n- The net yield from oxidative phosphorylation is $Y_{\\mathrm{ATP/glucose,\\,procyclic}} = 30$ ATP molecules per glucose molecule.\n- The glucose uptake rate is $r_{\\mathrm{glucose,\\,procyclic}} = 3$ glucose molecules per second.\n\nSubstituting these values into the governing equation:\n$$r_{\\mathrm{ATP,\\,procyclic}} = Y_{\\mathrm{ATP/glucose,\\,procyclic}} \\times r_{\\mathrm{glucose,\\,procyclic}}$$\n$$r_{\\mathrm{ATP,\\,procyclic}} = 30 \\times 3 = 90$$\nThe rate of ATP production in the procyclic form is $90$ molecules per second.\n\nFinally, the problem asks for the difference in instantaneous ATP production rates, defined as $\\Delta r_{\\mathrm{ATP}} = r_{\\mathrm{ATP,\\,procyclic}} - r_{\\mathrm{ATP,\\,bloodstream}}$.\nUsing the calculated rates:\n$$\\Delta r_{\\mathrm{ATP}} = 90 - 20$$\n$$\\Delta r_{\\mathrm{ATP}} = 70$$\nThe difference in ATP production rates is $70$ molecules per second.",
            "answer": "$$\\boxed{70}$$"
        },
        {
            "introduction": "In modern diagnostics, we often need to move beyond a simple \"yes\" or \"no\" to ask \"how much?\". For chronic Chagas disease, where parasite levels can be very low, quantitative Polymerase Chain Reaction (qPCR) is a vital tool for measuring pathogen load. This problem () guides you through the process of creating a qPCR standard curve, an essential step that translates raw laboratory fluorescence data (the $C_t$ value) into a meaningful biological quantity: the number of parasite equivalents in a sample.",
            "id": "4683951",
            "problem": "A laboratory is quantifying Trypanosoma cruzi kinetoplast deoxyribonucleic acid (kDNA) using Quantitative Polymerase Chain Reaction (qPCR). Assume the fundamental amplification principle that per cycle the amplicon count increases by a constant factor, and that detection occurs when the amplicon count reaches a fixed threshold. Let the cycle at which the fluorescence crosses this threshold be the threshold cycle $C_t$. Use these foundations to establish a linear standard curve connecting $C_t$ to the base-$10$ logarithm of the initial target copy number $N_0$.\n\nYou are provided the following empirically determined parameters and biological facts:\n\n- The observed slope of the $C_t$ versus $\\log_{10}(N_0)$ standard curve is $-3.3$.\n- A calibration point indicates $C_t = 25$ when the initial kDNA target copy number is $10^{4}$.\n- Each parasite contains $10^{4}$ copies of the targeted kDNA minicircle region, so $10^{4}$ kDNA target copies correspond to one parasite equivalent.\n\nFirst, derive the linear standard curve form from the amplification principle and use the provided calibration point to determine the intercept. Then, use the resulting standard curve to compute the number of parasite equivalents in an unknown sample that yields $C_t = 30$. Round your final result to four significant figures and report the answer as a number of parasite equivalents (dimensionless). Do not include units in your final answer.",
            "solution": "The problem is first validated to ensure it is scientifically sound, well-posed, and contains sufficient information for a unique solution. The given principles of qPCR amplification—exponential increase per cycle and a fixed detection threshold—are standard in molecular biology. The provided data, including the slope of the standard curve and a calibration point, are consistent with typical experimental results and are sufficient to define the required linear relationship. The biological context regarding *Trypanosoma cruzi* kDNA and parasite equivalents is accurate and relevant. The problem is therefore deemed valid.\n\nThe solution proceeds by first principles. The number of DNA amplicons, $N_c$, after $c$ cycles of polymerase chain reaction (PCR) is described by the exponential growth equation:\n$$ N_c = N_0 E^c $$\nwhere $N_0$ is the initial number of target molecules and $E$ is the amplification efficiency per cycle.\n\nThe threshold cycle, $C_t$, is defined as the cycle number at which the number of amplicons reaches a predetermined threshold, $N_{th}$. At this point:\n$$ N_{th} = N_0 E^{C_t} $$\n\nTo establish the relationship between $C_t$ and $N_0$, we take the base-$10$ logarithm of both sides of the equation:\n$$ \\log_{10}(N_{th}) = \\log_{10}(N_0 E^{C_t}) $$\nUsing the properties of logarithms, this becomes:\n$$ \\log_{10}(N_{th}) = \\log_{10}(N_0) + \\log_{10}(E^{C_t}) $$\n$$ \\log_{10}(N_{th}) = \\log_{10}(N_0) + C_t \\log_{10}(E) $$\n\nTo express $C_t$ as a function of $\\log_{10}(N_0)$, we rearrange the equation:\n$$ C_t \\log_{10}(E) = \\log_{10}(N_{th}) - \\log_{10}(N_0) $$\n$$ C_t = -\\frac{1}{\\log_{10}(E)} \\log_{10}(N_0) + \\frac{\\log_{10}(N_{th})}{\\log_{10}(E)} $$\n\nThis equation is in the form of a linear equation, $y = mx + b$, where $y = C_t$ and $x = \\log_{10}(N_0)$. The slope is $m = -\\frac{1}{\\log_{10}(E)}$ and the y-intercept is $b = \\frac{\\log_{10}(N_{th})}{\\log_{10}(E)}$. This confirms the linear standard curve mentioned in the problem.\n\nThe problem provides the empirically determined slope of the standard curve as $m = -3.3$. Thus, the equation for the standard curve is:\n$$ C_t = -3.3 \\cdot \\log_{10}(N_0) + b $$\n\nTo determine the intercept, $b$, we use the given calibration point: $C_t = 25$ when the initial kDNA target copy number is $N_0 = 10^4$. Substituting these values into the equation:\n$$ 25 = -3.3 \\cdot \\log_{10}(10^4) + b $$\nSince $\\log_{10}(10^4) = 4$, the equation simplifies to:\n$$ 25 = -3.3 \\cdot 4 + b $$\n$$ 25 = -13.2 + b $$\nSolving for $b$:\n$$ b = 25 + 13.2 = 38.2 $$\n\nThe complete equation for the standard curve is therefore:\n$$ C_t = -3.3 \\cdot \\log_{10}(N_0) + 38.2 $$\n\nNext, we use this standard curve to determine the initial copy number, $N_0$, in an unknown sample that yields a threshold cycle of $C_t = 30$.\n$$ 30 = -3.3 \\cdot \\log_{10}(N_0) + 38.2 $$\nWe solve for $\\log_{10}(N_0)$:\n$$ 3.3 \\cdot \\log_{10}(N_0) = 38.2 - 30 $$\n$$ 3.3 \\cdot \\log_{10}(N_0) = 8.2 $$\n$$ \\log_{10}(N_0) = \\frac{8.2}{3.3} $$\nThe initial number of kDNA copies in the unknown sample is:\n$$ N_0 = 10^{\\frac{8.2}{3.3}} $$\n\nThe problem asks for the result in terms of parasite equivalents. We are given that $1$ parasite equivalent corresponds to $10^4$ kDNA target copies. Let $P$ be the number of parasite equivalents.\n$$ P = \\frac{N_0}{10^4} $$\nSubstituting the expression for $N_0$:\n$$ P = \\frac{10^{\\frac{8.2}{3.3}}}{10^4} = 10^{\\left(\\frac{8.2}{3.3} - 4\\right)} $$\n\nNow, we compute the numerical value of $P$:\n$$ \\frac{8.2}{3.3} \\approx 2.484848... $$\n$$ P \\approx 10^{(2.484848... - 4)} = 10^{-1.515151...} $$\n$$ P \\approx 0.0305383... $$\n\nThe final step is to round the result to four significant figures. The first four significant figures of $0.0305383...$ are $3$, $0$, $5$, and $3$. The fifth significant figure is $8$. Since $8 \\ge 5$, we round up the fourth significant figure, $3$, to $4$.\nThe rounded number of parasite equivalents is $0.03054$.",
            "answer": "$$\\boxed{0.03054}$$"
        },
        {
            "introduction": "A diagnostic test's performance characteristics, like sensitivity and specificity, are intrinsic, but its real-world utility is not. The probability that a positive result is truly positive—the Positive Predictive Value (PPV)—critically depends on the prevalence of the disease in the population being tested. This exercise () uses the foundational principles of Bayes' theorem to demonstrate how a highly specific test for Chagas disease can still yield a surprising number of false positives in a low-prevalence setting, a crucial lesson for clinical interpretation.",
            "id": "4683936",
            "problem": "A serologic enzyme-linked immunosorbent assay (ELISA) is used in a rural screening program for Trypanosoma cruzi infection (Chagas disease). In this population, the prevalence of infection is $0.02$. The ELISA has sensitivity $0.95$ and specificity $0.98$. Using the fundamental definitions of sensitivity $\\Pr(+\\mid D)$, specificity $\\Pr(-\\mid \\neg D)$, and prevalence $\\Pr(D)$, together with Bayes’ theorem, derive from first principles the expression for the positive predictive value (PPV), defined as $\\Pr(D\\mid +)$, in terms of these quantities. Then compute the PPV for this test in this population. Express your final answer as a decimal number rounded to four significant figures.",
            "solution": "The problem requires the derivation of the positive predictive value (PPV) from first principles and its subsequent calculation for a specific screening scenario.\n\nLet $D$ be the event that an individual has the disease (*Trypanosoma cruzi* infection) and $\\neg D$ be the event that the individual does not have the disease. Let $+$ denote a positive test result and $-$ denote a negative test result.\n\nThe givens from the problem statement are:\n- The prevalence of the disease: $\\Pr(D) = 0.02$.\n- The sensitivity of the test: $\\Pr(+\\mid D) = 0.95$.\n- The specificity of the test: $\\Pr(-\\mid \\neg D) = 0.98$.\n\nThe positive predictive value (PPV) is defined as the probability that an individual has the disease given that they have received a positive test result. In conditional probability notation, this is $\\Pr(D\\mid +)$.\n\nTo derive an expression for $\\Pr(D\\mid +)$, we begin with Bayes' theorem:\n$$\n\\Pr(D\\mid +) = \\frac{\\Pr(+\\mid D) \\Pr(D)}{\\Pr(+)}\n$$\n\nThe numerator contains terms that are directly provided: the sensitivity, $\\Pr(+\\mid D)$, and the prevalence, $\\Pr(D)$.\n\nThe denominator, $\\Pr(+)$, is the unconditional probability of a positive test result. This can be calculated using the law of total probability. A positive test result can occur in two mutually exclusive scenarios: (1) the individual has the disease and tests positive (a true positive), or (2) the individual does not have the disease and tests positive (a false positive).\nMathematically, this is expressed as:\n$$\n\\Pr(+) = \\Pr(+\\cap D) + \\Pr(+\\cap \\neg D)\n$$\n\nUsing the definition of conditional probability, $\\Pr(A\\cap B) = \\Pr(A\\mid B) \\Pr(B)$, we can rewrite each term:\n$$\n\\Pr(+\\cap D) = \\Pr(+\\mid D) \\Pr(D)\n$$\n$$\n\\Pr(+\\cap \\neg D) = \\Pr(+\\mid \\neg D) \\Pr(\\neg D)\n$$\n\nSubstituting these into the expression for $\\Pr(+)$ yields:\n$$\n\\Pr(+) = \\Pr(+\\mid D) \\Pr(D) + \\Pr(+\\mid \\neg D) \\Pr(\\neg D)\n$$\n\nNow, we must express the terms on the right-hand side using the given quantities.\n- $\\Pr(+\\mid D)$ is the sensitivity.\n- $\\Pr(D)$ is the prevalence.\n- $\\Pr(\\neg D)$ is the probability of not having the disease, which is complementary to the prevalence: $\\Pr(\\neg D) = 1 - \\Pr(D)$.\n- $\\Pr(+\\mid \\neg D)$ is the probability of a positive test given no disease. This is the false positive rate. We are given the specificity, $\\Pr(-\\mid \\neg D)$, which is the probability of a negative test given no disease. Since for an individual without disease, the test can only be positive or negative, these two probabilities must sum to $1$:\n$$\n\\Pr(+\\mid \\neg D) + \\Pr(-\\mid \\neg D) = 1\n$$\nTherefore, the false positive rate is:\n$$\n\\Pr(+\\mid \\neg D) = 1 - \\Pr(-\\mid \\neg D) = 1 - \\text{specificity}\n$$\n\nBy substituting these expressions back into the equation for $\\Pr(+)$, we obtain the denominator in terms of the given quantities:\n$$\n\\Pr(+) = (\\text{sensitivity})(\\text{prevalence}) + (1 - \\text{specificity})(1 - \\text{prevalence})\n$$\n\nFinally, substituting this complete expression for $\\Pr(+)$ into the Bayes' theorem formula for $\\Pr(D\\mid +)$ gives the derived expression for the PPV:\n$$\n\\text{PPV} = \\Pr(D\\mid +) = \\frac{\\Pr(+\\mid D) \\Pr(D)}{\\Pr(+\\mid D) \\Pr(D) + (1 - \\Pr(-\\mid \\neg D))(1 - \\Pr(D))}\n$$\nThis completes the derivation from first principles.\n\nNow we compute the numerical value for the given population.\nThe provided values are:\n- $\\text{prevalence} = \\Pr(D) = 0.02$\n- $\\text{sensitivity} = \\Pr(+\\mid D) = 0.95$\n- $\\text{specificity} = \\Pr(-\\mid \\neg D) = 0.98$\n\nFrom these, we can calculate the complementary probabilities:\n- $1 - \\text{prevalence} = 1 - 0.02 = 0.98$\n- $1 - \\text{specificity} = 1 - 0.98 = 0.02$\n\nWe substitute these values into the derived formula for PPV:\n$$\n\\text{PPV} = \\frac{(0.95)(0.02)}{(0.95)(0.02) + (0.02)(0.98)}\n$$\n\nFirst, we calculate the numerator and the terms in the denominator:\n- Numerator: $0.95 \\times 0.02 = 0.019$\n- First term in denominator (true positives): $0.95 \\times 0.02 = 0.019$\n- Second term in denominator (false positives): $0.02 \\times 0.98 = 0.0196$\n\nNow, we sum the terms in the denominator:\n$$\n\\Pr(+) = 0.019 + 0.0196 = 0.0386\n$$\n\nFinally, we calculate the PPV:\n$$\n\\text{PPV} = \\frac{0.019}{0.0386} \\approx 0.49222797927...\n$$\n\nThe problem requires the final answer to be rounded to four significant figures. The first significant figure is $4$. The next three are $9$, $2$, and $2$. The fifth digit is $2$, which is less than $5$, so we round down (i.e., we do not change the fourth significant digit).\nThus, the PPV rounded to four significant figures is $0.4922$.",
            "answer": "$$\\boxed{0.4922}$$"
        }
    ]
}